MoneyWorks4Me

Makers Laboratories - Quaterly Results

08 Aug 2026 Evaluate
The sales declined to Rs. 101.88 millions for the June 2026 quarter as compared to Rs. 137.27 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2026 is Rs. -10.76 millions as compared to Net Loss of Rs. -2.71 millions of corresponding quarter ended June 2025Operating profit Margin for the quarter ended June 2026 slipped to -4.28% as compared to 5.02% of corresponding quarter ended June 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 101.88 137.27 -25.78 101.88 137.27 -25.78 503.47 429.45 17.24
Other Income 0.72 0.39 84.62 0.72 0.39 84.62 5.93 109.24 -94.57
PBIDT -4.28 5.02 -185.26 -4.28 5.02 -185.26 13.23 87.15 -84.82
Interest 1.36 1.02 33.33 1.36 1.02 33.33 5.31 9.40 -43.51
PBDT -5.64 4.00 -241.00 -5.64 4.00 -241.00 7.92 77.75 -89.81
Depreciation 6.94 6.99 -0.72 6.94 6.99 -0.72 28.04 28.46 -1.48
PBT -12.58 -2.99 320.74 -12.58 -2.99 320.74 -20.12 49.29 -140.82
TAX -1.82 -0.28 550.00 -1.82 -0.28 550.00 -2.92 2.87 -201.74
Deferred Tax -1.82 -0.28 550.00 -1.82 -0.28 550.00 -2.92 2.88 -201.39
PAT -10.76 -2.71 297.05 -10.76 -2.71 297.05 -17.20 46.42 -137.05
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 59.00 0.00
PBIDTM(%) -4.20 3.66 -214.88 -4.20 3.66 -214.88 2.63 20.29 -87.05
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..